Physician profile
Blake E S Taylor
NPI 1407210214
$8,943.34
in general payments reported to CMS, 2019-2025
19 companies · $2,755 in 2025
The $2,755 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,237 · 2024: $4,951 · 2025: $2,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,295 · Travel and Lodging: $2,649 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,294.50 |
| Travel and Lodging | $2,648.84 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $5,322.36 | 2024-2025 | Scarlet Al-T, Cure Acp |
| Medical Device Business Services, INC. | $1,123.66 | 2024 | Teligen |
| Medtronic, INC. | $594.18 | 2023-2025 | Unid_pass, Kyphon Express II Kyphopak Tray, Inceptiv |
| Spineology INC. | $489.38 | 2023-2024 | Optimesh Expandable Interbody Fusion System |
| Baxter Healthcare | $381.69 | 2023 | Actifuse |
| Stryker Corporation | $178.51 | 2023 | N/A |
| Next Science LLC | $134.76 | 2023 | Surgx, Xperience, Blastx |
| Kuros Biosciences USA, INC | $132.71 | 2025 | Magnetos |
| Providence Medical Technology, INC. | $107.28 | 2024 | |
| Icotec Medical INC. | $107.17 | 2023 | Icotec Blackarmor Spine System |
| Nuvasive, INC. | $61.85 | 2023 | Tlx, Xlif, Bendini |
| Ceribell, INC. | $58.14 | 2024 | Pocket Eeg Device |
| Mimedx Group, INC. | $56.95 | 2025 | |
| Integra Lifesciences Corporation | $45.27 | 2023 | Cusa Clarity, Codman Hakim, Codman Certas |
| Carlsmed, INC. | $43.24 | 2025 | Aprevo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $33.72 | 2024 | Andexxa |
| Centinel Spine, LLC | $30.03 | 2024 | Prodisc C Vivo |
| Abbott Laboratories | $24.91 | 2024 | Proclaim |
| Ethicon US, LLC | $17.53 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.